2022-2030 年按類型(體外、體內)、按產品(試劑和耗材、化驗、服務)、按應用、按地區、按細分市場劃分的基因毒性測試市場規模、份額、趨勢分析報告
市場調查報告書
商品編碼
1133325

2022-2030 年按類型(體外、體內)、按產品(試劑和耗材、化驗、服務)、按應用、按地區、按細分市場劃分的基因毒性測試市場規模、份額、趨勢分析報告

Genetic Toxicology Testing Market Size, Share & Trends Analysis Report By Type (In-vitro, In-vivo), By Product (Reagents & Consumables, Assays, Services), By Application, By Region, And Segment Forecasts, 2022 - 2030

出版日期: | 出版商: Grand View Research | 英文 150 Pages | 商品交期: 2-10個工作天內

價格

基因毒性測試市場的增長和趨勢

根據 Grand View Research, Inc. 的一份新報告,到 2030 年,全球基因毒理學檢測市場預計將達到 35.7 億美元。從 2022 年到 2030 年,市場預計將以 12.7% 的複合年增長率增長。隨著全球細胞和基因療法的發展,越來越多地使用個性化藥物,增加了對基因毒性的需求。例如,美國 FDA 已經為細胞和基因治療製造商制定了指導文件。根據該指南,在臨床前研究中確定毒性和生理參數的信息將有助於指導研究藥物的臨床監測。

越來越多地使用個性化醫療和採用藥物遺傳學來幫助降低藥物毒性的風險預計將對行業的發展產生重大影響。此外,荷蘭藥物遺傳學工作組(DPWG)、臨床藥物遺傳學實踐聯盟(CPIC)、法國藥物遺傳學國家網絡和加拿大藥物遺傳學網絡(CPNDS)等組織都在倡導藥物遺傳學檢測,並發布臨床指南專注於特定藥物基因對的解釋和治療建議。

同樣,市場公司正在沉迷於各種策略,以擴大其在多個領域的足跡。例如,2021 年 11 月,Labcorp 宣布收購提供非臨床測試服務的合同研究組織 (CRO) Toxikon。此次收購預計將加強 Labcorp 的毒理學業務,而 Toxikon 的位置將為 Labcorp 提供與該地區知名生物技術和製藥公司的非臨床合作。

預計 COVID-19 大流行將對基因毒性測試市場的增長產生中性影響。許多研究人員利用基因毒性來評估藥物對 COVID-19 病毒的功效。例如,2020 年 9 月,一組研究人員評估了氯奎 (CQ) 和羥氯奎 (HCQ) 作為病毒預防劑的作用。我們評估了各種藥物和化學品的遺傳毒性。此類研究使用遺傳毒性測試作為評估工具,預計將支持 COVID-19 高峰期間的穩定增長。

對新型食品及其進口的需求不斷增長,預計將有助於市場增長。Charles River Laboratories 是新型食品毒理學評估的領先供應商之一。他們提供新穎的食品分析,包括遺傳毒性,包括體內微核試驗、Ames 試驗、體外哺乳動物細胞微核和體內彗星試驗。同樣,2021 年 1 月,EFSA 發布了對昆蟲食品的評估。這是該機構對昆蟲產品作為一種新型食品進行的首次此類評估。EFSA 每年都會收到數十份申請,其中包括基於藻類食品、植物和非本地水果的草藥產品。

另一方面,通過基因毒理學提取信息是有限的。根據病理學測試評論組織,基因測試提供有關特定疾病或正在測試的基因的信息。它不包括有關可能存在的其他未經測試的遺傳疾病的信息。同樣,它不能識別導致疾病的基因中的所有突變,也不能表明疾病的嚴重程度。因此,預計這些限制將阻礙基因毒理學行業的發展。

遺傳毒理學檢測市場報告亮點

按類型劃分,預計 2021 年體外基因毒性檢測市場份額最大,增長最快。由於食品行業對基因毒性的監管要求不斷提高

通過應用,製藥和生物技術部門估計是市場的主要貢獻者。這是由於細胞和基因治療、藥物基因組學的發展以及越來越多地使用個性化醫療。

由於新型食品進口增加和檢驗法規收緊,尤其是在澳大利亞,預計亞太地區在預測期內將顯著增長。

從產品來看,隨著製藥和生物技術公司對非臨床試驗的需求增加,服務業將在 2021 年佔據很大份額。合同研究機構的戰略舉措增加也是一個關鍵的增長動力

由於存在滿足製藥和生物技術公司需求的高效參與者,北美是 2021 年基因毒理學的關鍵區域市場。個性化醫療的研發增加也是一個主要因素。

主要市場參與者包括 Thermo Fisher Scientific, Inc.、Charles River Laboratories International、Laboratory Corp of America Holdings 和 Eurofins Scientific。

目錄

第一章研究方法論

  • 市場細分和範圍
  • 調查方法
  • 信息採購
    • 購買的數據庫
    • GVR內部數據庫
    • 次要信息
    • 初步調查
    • 初步調查詳情
  • 信息或數據分析
    • 數據分析模型
  • 市場製定和驗證
  • 型號詳情
    • 商品流向分析
      • 方法一:商品流動方法
      • 方法 2:使用自下而上的方法按國家/地區進行市場預測
  • 全球市場:複合年增長率計算
  • 調查假設
  • 二級信息列表
  • 主要信息列表
  • 目的
  • 縮略語表

第二章市場定義

第三章執行摘要

  • 市場概況

4 全球基因毒性測試市場:變量、趨勢和範圍

  • 基因毒性測試市場的譜系展望
    • 母公司市場展望
  • 繪製滲透率和增長前景
  • 監管框架
  • 市場驅動力分析
    • 細胞和基因治療的發展
    • 越來越多地使用藥物基因組學和個性化醫療
    • 新食品進口增加
  • 市場約束因素分析
    • 對保險合同的模糊規定
    • 提供有限信息的能力
  • COVID-19 影響分析
  • 波特五力分析
  • SWOT分析

5 基因毒性測試市場:細分分析,按類型,2018-2030 年(百萬美元)

  • 全球基因毒性測試市場:變異分析
  • 體外
  • 體內

6. 基因毒性測試市場:細分分析,按產品,2018-2030 年(百萬美元)

  • 全球基因毒性測試市場:產品變異分析
  • 試劑和耗材
  • 化驗
  • 服務

7. 基因毒性測試市場:細分分析,按應用,2018-2030 年(百萬美元)

  • 基因毒性測試市場:應用變異分析
  • 製藥和生物技術
  • 食品工業
  • 化妝品行業
  • 其他

8. 2018-2030 年基因毒性檢測市場:細分分析,按地區劃分(百萬美元)

  • 基因毒性檢測市場:區域變異分析
  • 北美
    • 美國
    • 加拿大
  • 歐洲
    • 英國
    • 德國
    • 西班牙
    • 法國
    • 意大利
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 韓國
    • 澳大利亞
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
  • 中東和非洲 (MEA)
    • 南非
    • 沙特阿拉伯
    • 阿拉伯聯合酋長國

第 9 章 競爭格局

  • 上市公司
    • 公司市場分析
    • 競爭儀錶盤分析
    • 戰略框架
  • 民營企業
    • 關鍵初創企業/技術顛覆者/創新者名單
    • 區域網絡圖
  • 公司簡介
    • Thermo Fisher Scientific, Inc
      • 公司簡介
      • 財務績效
      • 產品基準
      • 戰略舉措
    • CHARLES RIVER LABORATORIES INTERNATIONAL
      • 公司簡介
      • 財務績效
      • 產品基準
      • 戰略舉措
    • Laboratory Corp of America Holdings
      • 公司簡介
      • 財務績效
      • 產品基準
      • 戰略舉措
    • EUROFINS SCIENTIFIC
      • 公司簡介
      • 財務績效
      • 產品基準
      • 戰略舉措
    • JUBILANT LIFE SCIENCES LIMITED
      • 公司簡介
      • 財務績效
      • 產品基準
      • 戰略舉措
    • SYNGENE INTERNATIONAL LIMITED
      • 公司簡介
      • 財務績效
      • 產品基準
      • 戰略舉措
    • GENTRONIX LTD.
      • 公司簡介
      • 財務績效
      • 產品基準
      • 戰略舉措
    • INOTIV INC.
      • 公司簡介
      • 財務績效
      • 產品基準
      • 戰略舉措
    • CREATIVE BIOARRAY
      • 公司簡介
      • 財務績效
      • 產品基準
      • 戰略舉措
    • MB RESEARCH LABORATORIES
      • 公司簡介
      • 財務績效
      • 產品基準
      • 戰略舉措
Product Code: GVR-4-68039-981-3

Genetic Toxicology Testing Market Growth & Trends:

The global genetic toxicology testing market size is expected to reach USD 3.57 billion by 2030, according to a new report by Grand View Research, Inc. The market is anticipated to expand at a CAGR of 12.7% from 2022 to 2030. The rising usage of personalized medicines, combined with the development of cell and gene therapy across the globe is enhancing the demand for genotoxicity. For instance, the U.S. FDA has designed guidance documents for the manufacturers of cell and gene therapy. According to the guidance, information on the identification of toxicities and physiologic parameters in preclinical studies can assist in guiding clinical monitoring for the investigational product.

Increasing implementation of pharmacogenomics to support personalized medicine usage and reduced risk of adverse drug toxicity is considered to have a significant impact on the growth of the industry. Moreover, organizations, such as the Dutch Pharmacogenetics Working Group (DPWG), Clinical Pharmacogenetics Implementation Consortium (CPIC), the French National Network of Pharmacogenetics, and the Canadian Pharmacogenomics Network for Drug Safety (CPNDS), have issued clinical guidelines with a primary focus on the pharmacogenomics testing interpretation and recommendation on therapeutic specific drug-gene pairs.

Similarly, the market players are indulging in various strategies to expand their footprint in multiple segments. For instance, in November 2021, Labcorp announced the acquisition of Toxikon, a Contract Research Organization (CRO) with offerings in nonclinical testing services. Through this acquisition, Labcorp is anticipated to strengthen its toxicology business and Toxikon's location enables Labcorp to engage with known biotech and pharmaceutical companies in the region for non-clinical work.

The COVID-19 pandemic is anticipated to have a neutral impact on the genetic toxicology testing market growth. Numerous researchers employed genotoxic to assess the effects of drugs against the COVID-19 virus. For instance, in September 2020, a team of researchers evaluated the impact of Chloroquine (CQ) and Hydroxychloroquine (HCQ) as prophylactic drugs against the virus. The genetic toxicology of various drugs and chemicals was assessed. Such studies using genetic toxicology testing as a tool of assessment are anticipated to support stable growth during the peak of COVID-19.

The rising demand for novel food and its imports is expected to be a contributor to market growth. Charles River Laboratories is one of the major players offering toxicology assessments on novel foods. They offer novel food analysis including genotoxicity, which consist of in vivo micronucleus test, Ames study, In Vitro Mammalian Cell Micronucleus, and in the vivo comet assay. Similarly, in January 2021, EFSA published its evaluation of insect-derived food. It is the first kind of assessment conducted by the institution on the insect product as a novel food. Every year, EFSA receives a large number of applications, consisting of herbal products based on algae foods, plants, and non-indigenous fruits.

On the other hand, the ability to retrieve information through genetic toxicology is limited. According to the Pathology Tests Explained organization, genetic tests offer information regarding the specific diseases/gene that is being tested. It does not cover information about other genetic diseases that might be present but have not been tested. Similarly, it cannot identify all the variations of genes that cause the diseases, and also it does not showcase the severity of the diseases. Hence, these limitations are anticipated to hamper the growth of the genetic toxicology industry.

Genetic Toxicology Testing Market Report Highlights:

  • By type, the in vitro is expected to be the fastest growing segment with the largest share of the Genetic Toxicology Testing Market in 2021. Owing to the rising requirement by regulatory agencies for genotoxicity in the food industry
  • By application, the pharmaceutical & biotechnology segment is estimated to become a major market contributor. This is attributed to an increase in the development of cell and gene therapy, coupled with increasing use of pharmacogenomics and personalized medicines
  • The Asia Pacific region is projected to grow substantially over the forecasted period owing to the increasing imports of novel food and tightening test regulations for the same, especially in Australia
  • By product, the service segment captured a significant proportion of the share in 2021, owing to the increasing demand by pharmaceutical and biotechnology companies for nonclinical works. Also, increasing strategic initiatives by contract research organizations is a major growth determinant
  • North America was a major regional market for genetic toxicology in 2021 owing to the availability of efficient players in the region to match the demand by pharma and biotech companies. The increasing R&D in personalized medicines is also a significant factor
  • Some of the main market players include Thermo Fisher Scientific, Inc.; Charles River Laboratories International; Laboratory Corp of America Holdings; and Eurofins Scientific

Table of Contents

Chapter 1 Research Methodology

  • 1.1 Market Segmentation & Scope
    • 1.1.1 Estimates And Forecast Timeline
  • 1.2 Research Methodology
  • 1.3 Information Procurement
    • 1.3.1 Purchased Database
    • 1.3.2 Gvr's Internal Database
    • 1.3.3 Secondary Sources
    • 1.3.4 Primary Research
    • 1.3.5 Details Of Primary Research
  • 1.4 Information or Data Analysis
    • 1.4.1 Data Analysis Models
  • 1.5 Market Formulation & Validation
  • 1.6 Model Details
    • 1.6.1 Commodity Flow Analysis
      • 1.6.1.1 Approach 1: Commodity flow approach
      • 1.6.1.2 Approach 2: Country - wise market estimation using a bottom - up approach
  • 1.7 Global Market: CAGR Calculation
  • 1.8 Research Assumptions
  • 1.9 List of Secondary Sources
  • 1.10 List of Primary Sources
  • 1.11 Objectives
    • 1.11.1 Objective 1:
    • 1.11.2 Objective 2:
  • 1.12 List Of Abbreviations

Chapter 2 Market Definitions

Chapter 3 Executive Summary

  • 3.1 Market Summary

Chapter 4 Global Genetic Toxicology Testing Market Variables, Trends, & Scope

  • 4.1 Genetic Toxicology Testing Market Lineage Outlook
    • 4.1.1 Parent Market Outlook
  • 4.2 Penetration and Growth Prospect Mapping
  • 4.3 Regulatory Framework
  • 4.4 Market Driver Analysis
    • 4.4.1 Development Of Cell And Gene Therapy
    • 4.4.2 Increasing Use Of Pharmacogenomics And Personalized Medicines
    • 4.4.3 Increasing Imports Of Novel Food
  • 4.5 Market Restraint Analysis
    • 4.5.1 Vague Regulations On Insurance Policy
    • 4.5.2 Ability To Offer Limited Information
  • 4.6 COVID - 19 Impact Analysis
  • 4.7 Porter's Five Forces Analysis
  • 4.8 SWOT Analysis

Chapter 5 Genetic Toxicology Testing Market - Segment Analysis, by type, 2018 - 2030 (USD Million)

  • 5.1 Global Genetic Toxicology Testing Market: Type Movement Analysis
  • 5.2 In Vitro
    • 5.2.1 In Vitro Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 5.3 In Vivo
    • 5.3.1 In Vivo Market Estimates And Forecast, 2018 - 2030 (USD Million)

Chapter 6 Genetic Toxicology Testing Market - Segment Analysis, by Product, 2018 - 2030 (USD Million)

  • 6.1 Global Genetic Toxicology Testing Market: Product Movement Analysis
  • 6.2 Reagents & Consumables
    • 6.2.1 Reagents & Consumables Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 6.3 Assays
    • 6.3.1 Assays Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 6.4 Services
    • 6.4.1 Services Market Estimates And Forecast, 2018 - 2030 (USD Million)

Chapter 7 Genetic Toxicology Testing Market - Segment Analysis, by Application, 2018 - 2030 (USD Million)

  • 7.1 Genetic Toxicology Testing Market: Application Movement Analysis
  • 7.2 Pharmaceutical & Biotechnology
    • 7.2.1 Pharmaceutical & Biotechnology Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 7.3 Food Industry
    • 7.3.1 Food Industry Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 7.4. Cosmetics Industry
    • 7.4.1 Cosmetics Industry Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 7.4. Other
    • 7.4.1 Other Market Estimates And Forecast, 2018 - 2030 (USD Million)

Chapter 8 Genetic Toxicology Testing Market: - Segment Analysis, by Region, 2018 - 2030 (USD Million)

  • 8.1 Genetic Toxicology Testing Market: Regional Movement Analysis
  • 8.2 North America
    • 8.2.1 North America Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 8.2.2 U.S.
      • 8.2.2.1 U.S. Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 8.2.3 Canada
      • 8.2.3.1 Canada Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 8.3 Europe
    • 8.3.1 Europe Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 8.3.2 U.K.
      • 8.3.2.1 U.K. market estimates and forecast, 2018 - 2030 (USD Million)
    • 8.3.3. Germany
      • 8.3.3.1 Germany Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 8.3.4 Spain
      • 8.3.4.1 Spain Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 8.3.5 France
      • 8.3.5.1 France Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 8.3.6 Italy
      • 8.3.6.1 Italy market estimates and forecast, 2018 - 2030 (USD Million)
  • 8.4 Asia Pacific
    • 8.4.1 Asia Pacific Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 8.4.2 Japan
      • 8.4.2.1 Japan Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 8.4.3 China
      • 8.4.3.1 China Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 8.4.4 India
      • 8.4.4.1 India Market Estimates And Forecast, 2018 - 2030
    • 8.4.5 South Korea
      • 8.4.5.1 South Korea market estimates and forecast, 2018 - 2030
    • 8.4.6 Australia
      • 8.4.6.1 Australia market estimates and forecast, 2018 - 2030
  • 8.5 Latin America
    • 8.5.1 Latin America Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 8.5.2 Brazil
      • 8.5.2.1 Brazil Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 8.5.3 Mexico
      • 8.5.3.1 Mexico Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 8.5.4 Argentina
      • 8.5.4.1 Argentina market estimates and forecast, 2018 - 2030 (USD Million)
  • 8.6 Middle East & Africa (MEA)
    • 8.6.1 Middle East & Africa Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 8.6.2 South Africa
      • 8.6.2.1 South Africa Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 8.6.3 Saudi Arabia
      • 8.6.3.1 Saudi Arabia market estimates and forecast, 2018 - 2030 (USD Million)
    • 8.6.4 UAE
      • 8.6.4.1 UAE market estimates and forecast, 2018 - 2030 (USD Million)

Chapter 9 Competitive Landscape

  • 9.1 Public Companies
    • 9.1.1 Company Market Position Analysis
    • 9.1.2 Competitive Dashboard Analysis
    • 9.1.3 Strategic Framework
  • 9.2 Private Companies
    • 9.2.1 List Of Key Emerging Companies/Technology Disruptors/Innovators
    • 9.2.2 Regional Network Map
  • 9.4 Company Profiles
    • 9.4.1 Thermo Fisher Scientific, Inc
      • 9.4.1.1 Company Overview
      • 9.4.1.2 Financial Performance
      • 9.4.1.3 Product Benchmarking
      • 9.4.1.4 Strategic Initiatives
    • 9.4.2 CHARLES RIVER LABORATORIES INTERNATIONAL
      • 9.4.2.1 Company Overview
      • 9.4.2.2 Financial Performance
      • 9.4.2.3 Product Benchmarking
      • 9.4.2.4 Strategic Initiatives
    • 9.4.3 Laboratory Corp of America Holdings
      • 9.4.3.1 Company Overview
      • 9.4.3.2 Financial Performance
      • 9.4.3.3 Product Benchmarking
      • 9.4.3.4 Strategic Initiatives
    • 9.4.4 EUROFINS SCIENTIFIC
      • 9.4.4.1 Company Overview
      • 9.4.4.2 Financial Performance
      • 9.4.4.3 Product Benchmarking
      • 9.4.4.4 Strategic Initiatives
    • 9.4.5 JUBILANT LIFE SCIENCES LIMITED
      • 9.4.5.1 Company Overview
      • 9.4.5.2 Financial Performance
      • 9.4.5.3 Product Benchmarking
      • 9.4.5.4 Strategic Initiatives
    • 9.4.6 SYNGENE INTERNATIONAL LIMITED
      • 9.4.6.1 Company Overview
      • 9.4.6.2 Financial Performance
      • 9.4.6.3 Product Benchmarking
      • 9.4.6.4 Strategic Initiatives
    • 9.4.7 GENTRONIX LTD.
      • 9.4.7.1 Company Overview
      • 9.4.7.2 Financial Performance
      • 9.4.7.3 Product Benchmarking
      • 9.4.7.4 Strategic Initiatives
    • 9.4.8 INOTIV INC.
      • 9.4.8.1 Company Overview
      • 9.4.8.2 Financial Performance
      • 9.4.8.3 Product Benchmarking
      • 9.4.8.4 Strategic Initiatives
    • 9.4.9 CREATIVE BIOARRAY
      • 9.4.9.1 Company Overview
      • 9.4.9.2 Financial Performance
      • 9.4.9.3 Product Benchmarking
      • 9.4.9.4 Strategic Initiatives
    • 9.4.10 MB RESEARCH LABORATORIES
      • 9.4.10.1 Company Overview
      • 9.4.10.2 Financial Performance
      • 9.4.10.3 Product Benchmarking
      • 9.4.10.4 Strategic Initiatives

List of Tables

  • Table 1 List of Secondary Sources
  • Table 2 List of Abbreviations
  • Table 3 Global Genetic Toxicology Testing Market, by Type, 2018 - 2030 (USD Million)
  • Table 4 Global Genetic Toxicology Testing Market, by Product 2018 - 2030 (USD Million)
  • Table 5 Global Genetic Toxicology Testing Market, by Application, 2018 - 2030 (USD Million)
  • Table 6 Global Genetic Toxicology Testing Market, by Region, 2018 - 2030 (USD Million)
  • Table 7 North America Genetic Toxicology Testing Market, by Country, 2018 - 2030 (USD Million)
  • Table 8 North America Genetic Toxicology Testing Market, by Type, 2018 - 2030 (USD Million)
  • Table 9 North America Genetic Toxicology Testing Market, by Product, 2018 - 2030 (USD Million)
  • Table 10 North America Genetic Toxicology Testing Market, by Application, 2018 - 2030 (USD Million)
  • Table 11 U.S. Genetic Toxicology Testing Market, by Type, 2018 - 2030 (USD Million)
  • Table 12 U.S. Genetic Toxicology Testing Market, by Product, 2018 - 2030 (USD Million)
  • Table 13 U.S. Genetic Toxicology Testing Market, by Application, 2018 - 2030 (USD Million)
  • Table 14 Canada Genetic Toxicology Testing Market, by Type, 2018 - 2030 (USD Million)
  • Table 15 Canada Genetic Toxicology Testing Market, by Product, 2018 - 2030 (USD Million)
  • Table 16 Canada Genetic Toxicology Testing Market, by Application, 2018 - 2030 (USD Million)
  • Table 17 Europe Genetic Toxicology Testing Market, by Country, 2018 - 2030 (USD Million)
  • Table 18 Europe Genetic Toxicology Testing Market, by Type, 2018 - 2030 (USD Million)
  • Table 19 Europe Genetic Toxicology Testing Market, by Product, 2018 - 2030 (USD Million)
  • Table 20 Europe Genetic Toxicology Testing Market, by Application, 2018 - 2030 (USD Million)
  • Table 21 Germany Genetic Toxicology Testing Market, by Type, 2018 - 2030 (USD Million)
  • Table 22 Germany Genetic Toxicology Testing Market, by Product, 2018 - 2030 (USD Million)
  • Table 23 Germany Genetic Toxicology Testing Market, by Application, 2018 - 2030 (USD Million)
  • Table 24 U.K. Genetic Toxicology Testing Market, by Type, 2018 - 2030 (USD Million)
  • Table 25 U.K. Genetic Toxicology Testing Market, by Product, 2018 - 2030 (USD Million)
  • Table 26 U.K. Genetic Toxicology Testing Market, by Application, 2018 - 2030 (USD Million)
  • Table 27 France Genetic Toxicology Testing Market, by Type, 2018 - 2030 (USD Million)
  • Table 28 France Genetic Toxicology Testing Market, by Product, 2018 - 2030 (USD Million)
  • Table 29 France Genetic Toxicology Testing Market, by Application, 2018 - 2030 (USD Million)
  • Table 30 Italy Genetic Toxicology Testing Market, by Type, 2018 - 2030 (USD Million)
  • Table 31 Italy Genetic Toxicology Testing Market, by Product, 2018 - 2030 (USD Million)
  • Table 32 Italy Genetic Toxicology Testing Market, by Application, 2018 - 2030 (USD Million)
  • Table 33 Spain Genetic Toxicology Testing Market, by Type, 2018 - 2030 (USD Million)
  • Table 34 Spain Genetic Toxicology Testing Market, by Product, 2018 - 2030 (USD Million)
  • Table 35 Spain Genetic Toxicology Testing Market, by Application, 2018 - 2030 (USD Million)
  • Table 36 Asia Pacific Genetic Toxicology Testing Market, by Country, 2018 - 2030 (USD Million)
  • Table 37 Asia Pacific Genetic Toxicology Testing Market, by Type, 2018 - 2030 (USD Million)
  • Table 38 Asia Pacific Genetic Toxicology Testing Market, by Product, 2018 - 2030 (USD Million)
  • Table 39 Asia Pacific Genetic Toxicology Testing Market, by Application, 2018 - 2030 (USD Million)
  • Table 40 China Genetic Toxicology Testing Market, by Type, 2018 - 2030 (USD Million)
  • Table 41 China Genetic Toxicology Testing Market, by Product, 2018 - 2030 (USD Million)
  • Table 42 China Genetic Toxicology Testing Market, by Application, 2018 - 2030 (USD Million)
  • Table 43 Japan Genetic Toxicology Testing Market, by Type, 2018 - 2030 (USD Million)
  • Table 44 Japan Genetic Toxicology Testing Market, by Product, 2018 - 2030 (USD Million)
  • Table 45 Japan Genetic Toxicology Testing Market, by Application, 2018 - 2030 (USD Million)
  • Table 46 India Genetic Toxicology Testing Market, by Type, 2018 - 2030 (USD Million)
  • Table 47 India Genetic Toxicology Testing Market, by Product, 2018 - 2030 (USD Million)
  • Table 48 India Genetic Toxicology Testing Market, by Application, 2018 - 2030 (USD Million)
  • Table 49 South Korea Genetic Toxicology Testing Market, by Type, 2018 - 2030 (USD Million)
  • Table 50 South Korea Genetic Toxicology Testing Market, by Product, 2018 - 2030 (USD Million)
  • Table 51 South Korea Genetic Toxicology Testing Market, by Application, 2018 - 2030 (USD Million)
  • Table 52 Australia Genetic Toxicology Testing Market, by Type, 2018 - 2030 (USD Million)
  • Table 53 Australia Genetic Toxicology Testing Market, by Product, 2018 - 2030 (USD Million)
  • Table 54 Australia Genetic Toxicology Testing Market, by Application, 2018 - 2030 (USD Million)
  • Table 55 Latin America Genetic Toxicology Testing Market, by Country, 2018 - 2030 (USD Million)
  • Table 56 Latin America Genetic Toxicology Testing Market, by Type, 2018 - 2030 (USD Million)
  • Table 57 Latin America Genetic Toxicology Testing Market, by Product, 2018 - 2030 (USD Million)
  • Table 58 Latin America Genetic Toxicology Testing Market, by Application, 2018 - 2030 (USD Million)
  • Table 59 Brazil Genetic Toxicology Testing Market, by Type, 2018 - 2030 (USD Million)
  • Table 60 Brazil Genetic Toxicology Testing Market, by Product, 2018 - 2030 (USD Million)
  • Table 61 Brazil Genetic Toxicology Testing Market, by Application, 2018 - 2030 (USD Million)
  • Table 62 Mexico Genetic Toxicology Testing Market, by Type, 2018 - 2030 (USD Million)
  • Table 63 Mexico Genetic Toxicology Testing Market, by Product, 2018 - 2030 (USD Million)
  • Table 64 Mexico Genetic Toxicology Testing Market, by Application, 2018 - 2030 (USD Million)
  • Table 65 Argentina Genetic Toxicology Testing Market, by Type, 2018 - 2030 (USD Million)
  • Table 66 Argentina Genetic Toxicology Testing Market, by Product, 2018 - 2030 (USD Million)
  • Table 67 Argentina Genetic Toxicology Testing Market, by Application, 2018 - 2030 (USD Million)
  • Table 68 Middle East & Africa Genetic Toxicology Testing Market, by Country, 2018 - 2030 (USD Million)
  • Table 69 Middle East & Africa Genetic Toxicology Testing Market, by Type, 2018 - 2030 (USD Million)
  • Table 70 Middle East & Africa Genetic Toxicology Testing Market, by Product, 2018 - 2030 (USD Million)
  • Table 71 Middle East & Africa Genetic Toxicology Testing Market, by Application, 2018 - 2030 (USD Million)
  • Table 72 South Africa Genetic Toxicology Testing Market, by Type, 2018 - 2030 (USD Million)
  • Table 73 South Africa Genetic Toxicology Testing Market, by Product, 2018 - 2030 (USD Million)
  • Table 74 South Africa Genetic Toxicology Testing Market, by Application, 2018 - 2030 (USD Million)
  • Table 75 Saudi Arabia Genetic Toxicology Testing Market, by Type, 2018 - 2030 (USD Million)
  • Table 76 Saudi Arabia Genetic Toxicology Testing Market, by Product, 2018 - 2030 (USD Million)
  • Table 77 Saudi Arabia Genetic Toxicology Testing Market, by Application, 2018 - 2030 (USD Million)
  • Table 78 UAE Genetic Toxicology Testing Market, by Type, 2018 - 2030 (USD Million)
  • Table 79 UAE Genetic Toxicology Testing Market, by Product, 2018 - 2030 (USD Million)
  • Table 80 UAE Genetic Toxicology Testing Market, by Application, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Information Procurement
  • Fig. 3 Primary Research Pattern
  • Fig. 4 Market Research Approaches
  • Fig. 5 Value Chain-Based Sizing & Forecasting
  • Fig. 6 Market Formulation & Validation
  • Fig. 7 Genetic Toxicology, Market Segmentation
  • Fig. 8 Market Snapshot, 2021
  • Fig. 9 Market Trends & Outlook
  • Fig. 10 Market Driver Relevance Analysis (Current & Future Impact)
  • Fig. 11 Market Restraint Relevance Analysis (Current & Future Impact)
  • Fig. 12 Market Challenge Relevance Analysis (Current & Future Impact)
  • Fig. 13 SWOT Analysis, By Factor (Political & Legal, Economic, and Technological)
  • Fig. 14 Porter's Five Forces Analysis
  • Fig. 15 Market Penetration Vs Growth Prospect Mapping, 2021
  • Fig. 16 Global Protein Expression Market: Type Movement Analysis
  • Fig. 17 Global Genetic Toxicology Testing Market, for In Vitro, 2018 - 2030 (USD Million)
  • Fig. 18 Global Genetic Toxicology Testing Market, for In Vivo, 2018 - 2030 (USD Million)
  • Fig. 19 Global Protein Expression Market: Product Movement Analysis
  • Fig. 20 Global Protein Expression Market, for Reagents & Consumables, 2018 - 2030 (USD Million)
  • Fig. 21 Global Genetic Toxicology Testing Market, for Assays, 2018 - 2030 (USD Million)
  • Fig. 22 Global Genetic Toxicology Testing Market, for Services, 2018 - 2030 (USD Million)
  • Fig. 23 Global Protein Expression Market: Application Movement Analysis
  • Fig. 24 Global Genetic Toxicology Testing Market, for Pharmaceutical; Biotechnology, 2018 - 2030 (USD Million)
  • Fig. 25 Global Genetic Toxicology Testing Market, for Food Industry, 2018 - 2030 (USD Million)
  • Fig. 26 Global Genetic Toxicology Testing Market, for Cosmetics Industry, 2018 - 2030 (USD Million)
  • Fig. 27 Global Genetic Toxicology Testing Market, for Other, 2018 - 2030 (USD Million)
  • Fig. 28 Regional Marketplace: Key Takeaways
  • Fig. 29 Regional Outlook, 2021 & 2030
  • Fig. 30 Global Genetic Toxicology Testing Market: Region Movement Analysis
  • Fig. 31 North America Genetic Toxicology Testing Market, 2018 - 2030 (USD Million)
  • Fig. 32 U.S. Genetic Toxicology Testing Market, 2018 - 2030 (USD Million)
  • Fig. 33 Canada Genetic Toxicology Testing Market, 2018 - 2030 (USD Million)
  • Fig. 34 Europe Genetic Toxicology Testing Market, 2018 - 2030 (USD Million)
  • Fig. 35 Germany Genetic Toxicology Testing Market, 2018 - 2030 (USD Million)
  • Fig. 36 U.K. Genetic Toxicology Testing Market, 2018 - 2030 (USD Million)
  • Fig. 37 France Genetic Toxicology Testing Market, 2018 - 2030 (USD Million)
  • Fig. 38 Italy Genetic Toxicology Testing Market, 2018 - 2030 (USD Million)
  • Fig. 39 Spain Genetic Toxicology Testing Market, 2018 - 2030 (USD Million)
  • Fig. 40 Asia Pacific Genetic Toxicology Testing Market, 2018 - 2030 (USD Million)
  • Fig. 41 Japan Genetic Toxicology Testing Market, 2018 - 2030 (USD Million)
  • Fig. 42 China Genetic Toxicology Testing Market, 2018 - 2030 (USD Million)
  • Fig. 43 India Genetic Toxicology Testing Market, 2018 - 2030 (USD Million)
  • Fig. 44 Australia Genetic Toxicology Testing Market, 2018 - 2030 (USD Million)
  • Fig. 45 South Korea Genetic Toxicology Testing Market, 2018 - 2030 (USD Million)
  • Fig. 46 Latin America Genetic Toxicology Testing Market, 2018 - 2030 (USD Million)
  • Fig. 47 Brazil Genetic Toxicology Testing Market, 2018 - 2030 (USD Million)
  • Fig. 48 Mexico Genetic Toxicology Testing Market, 2018 - 2030 (USD Million)
  • Fig. 49 Argentina Genetic Toxicology Testing Market, 2018 - 2030 (USD Million)
  • Fig. 50 Middle East and Africa Genetic Toxicology Testing Market, 2018 - 2030 (USD Million)
  • Fig. 51 South Africa Genetic Toxicology Testing Market, 2018 - 2030 (USD Million)
  • Fig. 52 Saudi Arabia Genetic Toxicology Testing Market, 2018 - 2030 (USD Million)
  • Fig. 53 UAE Genetic Toxicology Testing Market, 2018 - 2030 (USD Million)